Page 309 - Binder2

What began as a genetic code on a screen ends as a dose of
therapy inside a freeze-dried leaf. But the true story of
edible biologics isn’t just about scientific feasibility—it’s
about redesigning medicine to be more scalable, tolerable,
and human-centered.

From the patient who finally tolerizes a drug they once
rejected, to the rural community that can grow its own
therapy, edible biologics signal a future that is both
technologically advanced and profoundly grounded.

Gone are the assumptions that drugs must be injected,
refrigerated, or manufactured in distant mega-facilities. In
their place is a new model—decentralized, affordable,
shelf-stable, and rooted in biology as much as in
engineering.

Chapter 5 shows that this isn't merely a biotech experiment.
It’s the beginning of a harvest: one where medicine grows,
not just in labs, but in leaves—and where patients aren’t
just recipients, but partners in a newly planted paradigm.

This innovative and equitable future of biologics begins
whenever we want it to. We have the science and a plan to
implement it. So, what are we waiting for?

307